Assay Development and High-Throughput Screening of Small Molecular c-Abl Kinase Activators

被引:9
作者
Cottom, Josh
Hofmann, Glenn [2 ]
Siegfried, Brett [2 ]
Yang, Jingsong [3 ]
Zhang, Hong
Yi, Tracey
Ho, Thau F.
Quinn, Chad [4 ]
Wang, Da-Yuan
Johanson, Kyung
Ames, Robert S.
Li, Hu [1 ]
机构
[1] GlaxoSmithKline, Mol Discovery Res, Biol Reagents & Assay Dev, Collegeville, PA 19426 USA
[2] GlaxoSmithKline, Screening & Compound Profiling, Collegeville, PA 19426 USA
[3] GlaxoSmithKline, Oncol Res, Collegeville, PA 19426 USA
[4] GlaxoSmithKline, Analyt Chem, Collegeville, PA 19426 USA
关键词
c-Abl; kinase activator; HTS; IMAP; In-Cell Western; BacMam; TYROSINE KINASE; PROTEIN-KINASE; DOMAIN; INHIBITORS; CELL; MUTATION; A-769662; PATHWAY; BINDING; GENE;
D O I
10.1177/1087057110384133
中图分类号
Q5 [生物化学];
学科分类号
070307 [化学生物学];
摘要
A 2-step kinase assay was developed and used in a high-throughput screen (HTS) of more than 1 million compounds in an effort to identify c-Abl tyrosine kinase activators. This assay employed a 2-step phosphorylation reaction: in the first step, purified recombinant c-Abl was activated by incubating with compound in the presence of adenosine triphosphate (ATP). In the second step, the TA MRA-labeled IMAP Abltide substrate was added to allow phosphorylation of the substrate to occur. The assay was calibrated such that inactive c-Abl protein was activated by ATP alone to a degree that it not only demonstrated a measurable c-Abl activity but also maintained a robust assay window for screening. The screen resulted in 8624 primary hits with >30% response. Further analysis showed that 1024 had EC50 < 10 mu M with a max % response of >50%. These hits were structurally and chemically diverse with possibly different mechanisms for activating c-Abl. In addition, selective hits were shown to be cell permeable and were able to induce c-Abl activation as determined by In-Cell Western (ICW) analysis of HEK-MSRI cells transduced with BacMam virus expressing full-length c-Abl. (Journal of Biomolecular Screening 2011:53-64)
引用
收藏
页码:53 / 64
页数:12
相关论文
共 38 条
[1]
Allosteric inhibitors of Bcr-abl-dependent cell proliferation [J].
Adrián, FJ ;
Ding, Q ;
Sim, TB ;
Velentza, A ;
Sloan, C ;
Liu, Y ;
Zhang, GB ;
Hur, W ;
Ding, S ;
Manley, P ;
Mestan, J ;
Fabbro, D ;
Gray, NS .
NATURE CHEMICAL BIOLOGY, 2006, 2 (02) :95-102
[2]
Activated Abl kinase inhibits oncogenic transforming growth factor-β signaling and tumorigenesis in mammary tumors [J].
Allington, Tressa M. ;
Galliher-Beckley, Amy J. ;
Schiemann, William P. .
FASEB JOURNAL, 2009, 23 (12) :4231-4243
[3]
Evaluation of compound interference in immobilized metal ion affinity-based fluorescence polarization detection with a four million member compound collection [J].
Beasley, JR ;
Dunn, DA ;
Walker, TL ;
Parlato, SM ;
Lehrach, JM ;
Auld, DS .
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2003, 1 (03) :455-459
[4]
Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain [J].
Brasher, BB ;
Roumiantsev, S ;
Van Etten, RA .
ONCOGENE, 2001, 20 (53) :7744-7752
[5]
c-Ab1 has high intrinsic tyrosine kinase activity that is stimulated by mutation of the Src homology 3 domain and by autophosphorylation at two distinct regulatory tyrosines [J].
Brasher, BB ;
Van Etten, RA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (45) :35631-35637
[6]
Promiscuous Aggregate-Based Inhibitors Promote Enzyme Unfolding [J].
Coan, Kristin E. D. ;
Maltby, David A. ;
Burlingame, Alma L. ;
Shoichet, Brian K. .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (07) :2067-2075
[7]
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders [J].
Conn, P. Jeffrey ;
Christopoulos, Arthur ;
Lindsley, Craig W. .
NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (01) :41-54
[8]
Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome [J].
Cool, Barbara ;
Zinker, Bradley ;
Chiou, William ;
Kifle, Lemma ;
Cao, Ning ;
Perham, Matthew ;
Dickinson, Robert ;
Adler, Andrew ;
Gagne, Gerard ;
Iyengar, Rajesh ;
Zhao, Gang ;
Marsh, Kennan ;
Kym, Philip ;
Jung, Paul ;
Camp, Heidi S. ;
Frevert, Ernst .
CELL METABOLISM, 2006, 3 (06) :403-416
[9]
Phosphorylation and structure-based functional studies reveal a positive and a negative role for the activation loop of the c-Abl tyrosine kinase [J].
Dorey, K ;
Engen, JR ;
Kretzschmar, J ;
Wilm, M ;
Neubauer, G ;
Schindler, T ;
Superti-Furga, G .
ONCOGENE, 2001, 20 (56) :8075-8084
[10]
Inhibitors of the Abl kinase directed at either the ATP- or myristate-binding site [J].
Fabbro, Doriano ;
Manley, Paul W. ;
Jahnke, Wolfgang ;
Liebetanz, Janis ;
Szyttenholm, Alexandra ;
Fendrich, Gabriele ;
Strauss, Andre ;
Zhang, Jianming ;
Gray, Nathanael S. ;
Adrian, Francisco ;
Warmuth, Markus ;
Pelle, Xavier ;
Grotzfeld, Robert ;
Berst, Frederic ;
Marzinzik, Andreas ;
Cowan-Jacob, Sandra W. ;
Furet, Pascal ;
Mestan, Juergen .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2010, 1804 (03) :454-462